Krishna Institute of Medical Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 332.70 | 308.70 | 306.29 |
| Operating Expense | 233.60 | 218.50 | 214.58 |
| Net Profit | 60.70 | 48.20 | 58.36 |
| Net Profit Margin | 18.24 | 15.61 | 19.05 |
| Earning Per Share | 7.58 | 6.02 | 7.29 |
| EBIDTA | 100 | 90.70 | 91.61 |
| Effective Tax Rate | 22.00 | 21.95 | 20.99 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 332.70 |
| Operating Expense | 233.60 |
| Net Profit | 60.70 |
| Net Profit Margin | 18.24 |
| Earning Per Share | 7.58 |
| EBIDTA | 100.00 |
| Effective Tax Rate | 22.00 |
Invest in Krishna Institute of Medical Sciences Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,222.05 | 1,132.02 | 1,143.38 |
| Operating Expenses Annual | 857.65 | 771.74 | 747.16 |
| Operating Profit Annual | 379.94 | 383.78 | 420.39 |
| Interest Annual | 3.66 | 1.15 | 4.47 |
| Depreciation | 53.31 | 41.94 | 42.90 |
| Net Profit Annual | 235.34 | 252.49 | 278.37 |
| Tax Annual | 82.83 | 84.84 | 92.64 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,222.05 |
| Operating Expenses Annual | 857.65 |
| Operating Profit Annual | 379.94 |
| Interest Annual | 3.66 |
| Depreciation | 53.31 |
| Net Profit Annual | 235.34 |
| Tax Annual | 82.83 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 38.10 | 19.86 | 34.59 |
| Cash Flow from Operations | 262.39 | 271.05 | 284.37 |
| Cash Flow from Investing | -568.65 | -237.67 | -375.08 |
| Cash Flow from Financing | 288.64 | -15.14 | 75.98 |
| Cash Flow at the End | 20.48 | 38.10 | 19.86 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 38.10 |
| Cash Flow from Operations | 262.39 |
| Cash Flow from Investing | -568.65 |
| Cash Flow from Financing | 288.64 |
| Cash Flow at the End | 20.48 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 31.40 | 34.22 | 37.16 |
| PBIT Margin (%) | 26.65 | 30.22 | 33.23 |
| PBT Margin (%) | 23.09 | 23.92 | 29.50 |
| Net PROFIT Margin (%) | 19.26 | 22.30 | 24.35 |
| Return On Networth / Equity (%) | 13.46 | 16.79 | 24.15 |
| Return On Networth /Employed (%) | 16.77 | 22.23 | 30.50 |
| Return On Assets (%) | 12.13 | 16.51 | 22.64 |
| Total Debt / Equity (X) | 0.09 | 0.01 | 0.07 |
| Asset Turnover Ratio (%) | 0.63 | 0.74 | 0.93 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 31.40 |
| PBIT Margin (%) | 26.65 |
| PBT Margin (%) | 23.09 |
| Net PROFIT Margin (%) | 19.26 |
| Return On Networth / Equity (%) | 13.46 |
| Return On Networth /Employed (%) | 16.77 |
| Return On Assets (%) | 12.13 |
| Total Debt / Equity (X) | 0.09 |
| Asset Turnover Ratio (%) | 0.63 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 673.92 | 612.28 | 591.97 |
| Total Current Assets Annual | 301.17 | 237.04 | 331.28 |
| Non Current Assets Annual | 2,095.34 | 1,575.02 | 1,237.50 |
| Total Shareholders Funds Annual | 1,866.45 | 1,630.86 | 1,377.55 |
| Total Assets Annual | 2,396.51 | 1,812.07 | 1,568.78 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 673.92 |
| Total Current Assets Annual | 301.17 |
| Non Current Assets Annual | 2,095.34 |
| Total Shareholders Funds Annual | 1,866.45 |
| Total Assets Annual | 2,396.51 |
EPS (INR)
Expected
10.83
Reported
10.82
Surprise
-0.09%
Mar 2024
EPS beaten by -0.09%
Dec 2023
EPS beaten by -0.12%
Sep 2023
EPS beaten by 0.00%
